Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELP | P16109 | 1/20 | 0.69 |
| ▸ | PRKCA | P17252 | 2/20 | 0.63 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.63 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.63 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.63 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.61 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.55 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.55 |
| ▸ | FAAH | O00519 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | CNR1 | P21554 | 1/20 | 0.55 |
| ▸ | CNR2 | P34972 | 1/20 | 0.55 |
| ▸ | DGKA | P23743 | 1/20 | 0.54 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.53 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.53 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2228662 | 0.99 | SELP (0.68) | SELPPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL3408169 | 0.97 | SELP (0.65) | SELPPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL7076073 | 0.97 | PRKCA (0.67) | SELPPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL457068 | 0.97 | PRKCA (0.67) | SELPPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL1893444 | 0.97 | PRKCA (0.67) | SELPPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL565670 | 0.97 | PRKCA (0.67) | SELPPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL3403845 | 0.97 | PRKCA (0.67) | SELPPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL3410462 | 0.94 | SELP (0.61) | SELPPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL4195003 | 0.92 | PRKCA (0.60) | SELPPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL42345 | 0.91 | ALDH1A1 (0.63) | SELPPRKCAPRKCEPRKCQPRKCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12622979-B2 | Lipid nanoparticle used for delivering nucleic acid to brain tissue | NOF CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| US-20260115316-A1 | LIPID NANOPARTICLES FOR DELIVERING NUCLEIC ACID TO SPLENIC TISSUE, AND METHOD FOR DELIVERING NUCLEIC ACID TO SPLENIC TISSUE USING SAME | NOF CORPORATION (JP) | 2026-04-30 | — | — | US | disclosed |
| US-20250197852-A1 | LIPID NANOPARTICLES USED TO TRANSPORT NUCLEIC ACIDS INTO LYMPHATIC ENDOTHELIUM CELLS | NOF CORPORATION (JP) | 2025-06-19 | — | — | US | disclosed |
| EP-4501360-A1 | LIPID NANOPARTICLES FOR DELIVERING NUCLEIC ACID TO SPLENIC TISSUE, AND METHOD FOR DELIVERING NUCLEIC ACID TO SPLENIC TISSUE USING SAME | NOF Corporation (JP) | 2025-02-05 | — | — | EP | disclosed |
| US-20240408230-A1 | LIPID NANOPARTICLE USED FOR DELIVERING NUCLEIC ACID TO BRAIN TISSUE | NOF CORPORATION (JP) | 2024-12-12 | — | — | US | disclosed |
| EP-4410276-A1 | LIPID NANOPARTICLES USED TO TRANSPORT NUCLEIC ACIDS INTO LYMPHATIC ENDOTHELIUM CELLS | NOF Corporation (JP) | 2024-08-07 | — | — | EP | disclosed |
| EP-4410275-A1 | LIPID NANOPARTICLE USED FOR DELIVERING NUCLEIC ACID TO BRAIN TISSUE | NOF Corporation (JP) | 2024-08-07 | — | — | EP | disclosed |
| WO-2023190176-A1 | LIPID NANOPARTICLES FOR DELIVERING NUCLEIC ACID TO SPLENIC TISSUE, AND METHOD FOR DELIVERING NUCLEIC ACID TO SPLENIC TISSUE USING SAME | 日油株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023054242-A1 | LIPID NANOPARTICLES USED TO TRANSPORT NUCLEIC ACIDS INTO LYMPHATIC ENDOTHELIUM CELLS | 日油株式会社 | 2023-04-06 | — | — | WO | disclosed |
| WO-2023054241-A1 | LIPID NANOPARTICLE USED FOR DELIVERING NUCLEIC ACID TO BRAIN TISSUE | 日油株式会社 | 2023-04-06 | — | — | WO | disclosed |
| WO-2010126319-A2 | LIPOPEPTIDE WITH SPECIFIC AFFINITY TO THE FC REGION OF AN ANTIBODY, AND ANTIGEN-RECOGNIZING LIPID NANOPARTICLE COMPRISING SAME | 고려대학교 산학협력단 (KR) | 2010-11-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115316-A1 | LIPID NANOPARTICLES FOR DELIVERING NUCLEIC ACID TO SPLENIC TISSUE, AND METHOD FOR DELIVERING NUCLEIC ACID TO SPLENIC TISSUE USING SAME | SREBF1, SREBF2, FABP1 | SELP 1386/4885PRKCA 1327/4885PRKCE 1888/4885 |
| US-20250197852-A1 | LIPID NANOPARTICLES USED TO TRANSPORT NUCLEIC ACIDS INTO LYMPHATIC ENDOTHELIUM CELLS | LIPG, NPC1L1, FLT1 | SELP 183/4885PRKCA 2341/4885PRKCE 3302/4885 |
| US-20240408230-A1 | LIPID NANOPARTICLE USED FOR DELIVERING NUCLEIC ACID TO BRAIN TISSUE | PHOSPHO1, FABP7, SGMS1 | SELP 2037/4885PRKCA 1897/4885PRKCE 2925/4885 |
| US-12622979-B2 | Lipid nanoparticle used for delivering nucleic acid to brain tissue | FABP7, SREBF1, SREBF2 | SELP 3299/4885PRKCA 1816/4885PRKCE 2019/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.